Johnson & Johnson said on Tuesday its chemotherapy-free combination treatment showed a meaningful improvement in extending ...

AstraZeneca (AZN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Sachin Jain from Bank ...

If you suffered losses exceeding $100,000 in AstraZeneca between between February 23, 2022 and December 17, 2024 and would ...

Shares of AstraZeneca PLC AZN inched up 0.81% to £107.54 Wednesday, on what proved to be an all-around positive trading ...

Novo Nordisk (NYSE: NVO) and AstraZeneca (NASDAQ: AZN) are among the largest companies in the pharmaceutical industry. Both ...

The latest trading day saw Astrazeneca (AZN) settling at $66.58, representing a -0.09% change from its previous close.

AZN's key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Fasenra are likely to drive sales. It has several candidates ...

AstraZeneca has been taking a wider role in Vietnam’s healthcare sector to help expand access to quality healthcare.

UBS has recently raised AstraZeneca PLC (AZN) stock to Neutral rating, as announced on November 20, 2024, according to Finviz. Earlier, on November 6, 2024, Deutsche Bank had raised the stock from a ...

AstraZeneca India has laid off over 125 employees in its biopharmaceutical business unit, including senior managers and sales ...

AstraZeneca continues to advance its ambition to revolutionise cancer care with pivotal data presented for lung, gastrointestinal (GI), and breast cancers at the recent ESMO Asia Congress 2024. With a ...